Major determinants of delayed access to innovative medicines for metastatic melanoma: the results of Melanoma World Society and European Association of Dermato-Oncology survey
Authors
Sekulovic, LAgarwala, S
Hauschild, A
Guo, J
McArthur, G
Lorigan, Paul C
Cinat, G
Caglevich, C
Lebbe, C
Rutkowski, P
Gogas, H
Dummer, R
Neyns, B
Bastholt, L
Wainstein, A
Herceg, D
Banjin, M
Zhukavets, A
Ocvirk, J
Garbe, C
Affiliation
Dermatology, School of Medicine, Military Medical Academy, Belgrade, SerbiaIssue Date
2018
Metadata
Show full item recordCitation
Kandolf Sekulovic LO, Agarwala SS, Hauschild A, Guo J, McArthur GA, Lorigan P, et al. 1560PD Major determinants of delayed access to innovative medicines for metastatic melanoma: the results of Melanoma World Society and European Association of Dermato-Oncology survey. Ann Oncol. 2018;29(suppl_8):563.Journal
Annals of OncologyDOI
10.1093/annonc/mdy297.004Additional Links
https://dx.doi.org/10.1093/annonc/mdy297.004Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy297.004